Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Alexander J, Kovalic"'
Autor:
David Bernstein, Alexander J. Kovalic
Publikováno v:
Metabolism Open, Vol 13, Iss , Pp 100158- (2022)
Nonalcoholic fatty liver disease [NAFLD] is a condition affecting a vast portion of the worldwide population. The presence of underlying fibrosis is the strongest predictor of long-term outcomes and mortality, with a graduated increase in liver-relat
Externí odkaz:
https://doaj.org/article/180724b6f6404eb390f03ccd1f8a20e4
Publikováno v:
European Journal of Gastroenterology & Hepatology. 35:102-111
Fibrosis impacts long-term outcomes among patients with nonalcoholic fatty liver disease (NAFLD). Due to well-documented flaws associated with liver biopsy, there has been a recent emphasis on prioritizing noninvasive testing over liver biopsy for th
Publikováno v:
Hepatology. 76
Publikováno v:
Clinics in liver disease. 26(2)
Renal function is intricately tied to Model for End-Stage Liver Disease score and overall prognosis among patients with cirrhosis. The estimation of glomerular filtration rate (GFR) and etiology of renal impairment are even more magnified among cirrh
Autor:
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain
Publikováno v:
Nutrients, Vol 11, Iss 9, p 2172 (2019)
High tissue iron levels are a risk factor for multiple chronic diseases including type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). To investigate causal relationships and underlying mechanisms, we used an established NAF
Externí odkaz:
https://doaj.org/article/14889f3ad3f042879777322d65b454f8
Autor:
Alexander J. Kovalic
Publikováno v:
J Clin Exp Hepatol
BACKGROUND: Due to lack of targeted treatment options and inconsistent utilization of histologic endpoints among clinical trials, identifying efficacious pharmacotherapies for nonalcoholic steatohepatitis [NASH] has proven challenging. METHODS: A tho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d0013e2b84f3faa85419b9eaa2fde64
https://europepmc.org/articles/PMC9257887/
https://europepmc.org/articles/PMC9257887/
Publikováno v:
Hepatology International
Abnormal liver enzymes are seen in 20% of hospitalized patients with COVID-19. The etiology of elevated liver enzymes is thought to be multifactorial including medications and underlying liver disease. The true prevalence and clinical significance of
Publikováno v:
Gastroenterology Clinics of North America. 49:151-164
Nonalcoholic fatty liver disease includes a spectrum of liver disorders that range from simple steatosis to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. Risk factors such as obesity, hypertension, hyperlipidemia, chronic kidney disea
Publikováno v:
Diagnostic microbiology and infectious disease. 101(2)
Injection drug use (IDU) is a risk factor for infective endocarditis (IE) and hepatitis C virus (HCV) infection. This retrospective cohort study assessed HCV's impact on outcomes of adult people who inject drugs (PWID). Those admitted due to IE using
Publikováno v:
Variceal Bleeding in Liver Cirrhosis ISBN: 9789811572487
Variceal hemorrhage is a serious complication of cirrhosis and associated with significant morbidity and mortality. After initial treatment of an index variceal bleeding event, secondary prevention of variceal hemorrhage is of upmost importance. Nume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91e9060ec5fb92769f92edfe8f16f752
https://doi.org/10.1007/978-981-15-7249-4_7
https://doi.org/10.1007/978-981-15-7249-4_7